Why Science? | Bioprocessing Technology Institute

A*STAR presents BTI’s mission around quality processes for proteins, cells and nucleic acids. The institute joins biological discovery with engineering, formulation and analytical science. A project must specify the modality because an antibody, living cell and RNA medicine behave differently.

Biomanufacturing treats the process as part of the product because cells, media, equipment and control conditions shape quality. The practical capability is institutional literacy. Keep the question, input provenance, method version, controls, uncertainty, review and next decision in one evidence receipt. That record keeps curiosity optimistic and claims proportional to what was actually measured. BTI and authorised collaborators control current processes, facilities and released results; product sponsors, quality systems and regulators control manufacturing and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Create a one-page evidence card for “BTI focuses on quality biomanufacturing” with the source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: The institute mission does not certify a particular product.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Next chapter

Cell lines or primary cells convert nutrients into a desired biological product. Identity, genetic stability and history affect performance. Cell-bank records and controlled thawing protect continuity across experiments and manufacturing campaigns.

Scale-up changes oxygen, mixing, heat, stress and purification, so a successful small culture starts a new evidence stage rather than finishing development. The practical capability is cell-system stewardship. Keep the question, input provenance, method version, controls, uncertainty, review and next decision in one evidence receipt. That record keeps curiosity optimistic and claims proportional to what was actually measured. BTI and authorised collaborators control current processes, facilities and released results; product sponsors, quality systems and regulators control manufacturing and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Create a one-page evidence card for “The production cell is part of the process” with the source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Cells with the same name may diverge through handling or passage.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Culture media supply carbon, nitrogen, salts, vitamins and signals. Maximising cell number may not maximise product quality. Designed experiments and mechanistic models can compare trade-offs while keeping ingredient lots and preparation records visible.

Analytical methods connect identity, purity, potency and process understanding, letting teams find variation before it reaches later decisions. The practical capability is bioprocess media design. Keep the question, input provenance, method version, controls, uncertainty, review and next decision in one evidence receipt. That record keeps curiosity optimistic and claims proportional to what was actually measured. BTI and authorised collaborators control current processes, facilities and released results; product sponsors, quality systems and regulators control manufacturing and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Create a one-page evidence card for “Media design balances growth and quality” with the source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A productive medium at small scale may not transfer unchanged.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Bioreactors regulate temperature, pH, gases, mixing and feeding. Sensors describe selected conditions, while cells may experience local gradients. Control strategies need calibrated measurements and a clear connection to critical quality attributes.

Cells, proteins and nucleic acids need different production and delivery strategies, with safety and regulation governing every translation step. The practical capability is bioreactor control. Keep the question, input provenance, method version, controls, uncertainty, review and next decision in one evidence receipt. That record keeps curiosity optimistic and claims proportional to what was actually measured. BTI and authorised collaborators control current processes, facilities and released results; product sponsors, quality systems and regulators control manufacturing and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Create a one-page evidence card for “Bioreactors control the cellular environment” with the source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A stable controller signal may hide conditions elsewhere in the vessel.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Larger vessels change mixing time, oxygen transfer, heat removal and shear. Engineers choose scale criteria and test how the cells and product respond. Scale-down models can reproduce important stresses before expensive pilot runs.

Biomanufacturing treats the process as part of the product because cells, media, equipment and control conditions shape quality. The practical capability is scale-up engineering. Keep the question, input provenance, method version, controls, uncertainty, review and next decision in one evidence receipt. That record keeps curiosity optimistic and claims proportional to what was actually measured. BTI and authorised collaborators control current processes, facilities and released results; product sponsors, quality systems and regulators control manufacturing and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Create a one-page evidence card for “Scale-up changes transport and stress” with the source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Equal volume ratios do not guarantee equivalent cellular conditions.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Continuous and intensified bioprocessing can raise productivity or reduce footprint by integrating operations. Longer runs demand contamination control, steady-state evidence and robust monitoring. Comparisons should include quality, downtime, resources and failure recovery.

Scale-up changes oxygen, mixing, heat, stress and purification, so a successful small culture starts a new evidence stage rather than finishing development. The practical capability is continuous-bioprocess evaluation. Keep the question, input provenance, method version, controls, uncertainty, review and next decision in one evidence receipt. That record keeps curiosity optimistic and claims proportional to what was actually measured. BTI and authorised collaborators control current processes, facilities and released results; product sponsors, quality systems and regulators control manufacturing and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Create a one-page evidence card for “Process intensification changes the workflow” with the source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Higher throughput does not automatically mean lower cost or risk.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Downstream processing may combine filtration, chromatography and concentration. Product variants, host-cell proteins, DNA and aggregates can be difficult to separate. Recovery yield must be considered alongside purity and biological activity.

Analytical methods connect identity, purity, potency and process understanding, letting teams find variation before it reaches later decisions. The practical capability is downstream-processing literacy. Keep the question, input provenance, method version, controls, uncertainty, review and next decision in one evidence receipt. That record keeps curiosity optimistic and claims proportional to what was actually measured. BTI and authorised collaborators control current processes, facilities and released results; product sponsors, quality systems and regulators control manufacturing and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Create a one-page evidence card for “Purification removes closely related impurities” with the source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A high purification yield may retain unacceptable impurities.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

BTI’s analytical science covers characterisation of modalities and processes. Identity, purity, structure, potency and stability require complementary methods. Assay precision, reference standards and suitability for the intended stage determine confidence.

Cells, proteins and nucleic acids need different production and delivery strategies, with safety and regulation governing every translation step. The practical capability is analytical strategy. Keep the question, input provenance, method version, controls, uncertainty, review and next decision in one evidence receipt. That record keeps curiosity optimistic and claims proportional to what was actually measured. BTI and authorised collaborators control current processes, facilities and released results; product sponsors, quality systems and regulators control manufacturing and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Create a one-page evidence card for “Analytics define what quality means” with the source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Passing one analytical test does not establish complete product quality.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Proteomics, metabolomics and glycomics can reveal how cells and products change during culture. These high-dimensional measurements need sampling plans, controls and multiple-testing discipline. A molecular signature becomes useful when tied to a process decision.

Biomanufacturing treats the process as part of the product because cells, media, equipment and control conditions shape quality. The practical capability is bioprocess omics. Keep the question, input provenance, method version, controls, uncertainty, review and next decision in one evidence receipt. That record keeps curiosity optimistic and claims proportional to what was actually measured. BTI and authorised collaborators control current processes, facilities and released results; product sponsors, quality systems and regulators control manufacturing and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Create a one-page evidence card for “Omics can diagnose process behaviour” with the source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: An omics correlation is not automatically a controllable cause.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Models can connect material balances, kinetics and sensor data to hidden process states. AI may help anticipate deviations when training data represent operating conditions. Human reviewers need uncertainty and fallback rules before changing a live process.

Scale-up changes oxygen, mixing, heat, stress and purification, so a successful small culture starts a new evidence stage rather than finishing development. The practical capability is process modelling. Keep the question, input provenance, method version, controls, uncertainty, review and next decision in one evidence receipt. That record keeps curiosity optimistic and claims proportional to what was actually measured. BTI and authorised collaborators control current processes, facilities and released results; product sponsors, quality systems and regulators control manufacturing and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Create a one-page evidence card for “Mechanistic models support adaptive control” with the source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A model forecast does not replace validated control or operator responsibility.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Monoclonal, multispecific and conjugated antibodies require correct sequence, folding, glycosylation, assembly and activity. Engineering one property may alter another. Product and process development therefore advance through linked design and analytical evidence.

Analytical methods connect identity, purity, potency and process understanding, letting teams find variation before it reaches later decisions. The practical capability is protein-modality development. Keep the question, input provenance, method version, controls, uncertainty, review and next decision in one evidence receipt. That record keeps curiosity optimistic and claims proportional to what was actually measured. BTI and authorised collaborators control current processes, facilities and released results; product sponsors, quality systems and regulators control manufacturing and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Create a one-page evidence card for “Protein modalities have distinct attributes” with the source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Binding activity alone does not establish therapeutic performance.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

A cell therapy product is a population of living cells whose identity, viability, potency and unwanted states require control. Collection, expansion, manipulation, freezing and delivery can change the cells. Closed handling and traceability are central.

Cells, proteins and nucleic acids need different production and delivery strategies, with safety and regulation governing every translation step. The practical capability is cell-therapy manufacturing. Keep the question, input provenance, method version, controls, uncertainty, review and next decision in one evidence receipt. That record keeps curiosity optimistic and claims proportional to what was actually measured. BTI and authorised collaborators control current processes, facilities and released results; product sponsors, quality systems and regulators control manufacturing and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Create a one-page evidence card for “Cell therapies preserve living function” with the source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Viable cells are not necessarily correctly identified or potent.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

BTI describes strategies for efficient, cell-type-specific delivery of RNA and genetic material. The carrier influences protection, biodistribution and immune response. Sequence, formulation, dose and route need joint testing.

Biomanufacturing treats the process as part of the product because cells, media, equipment and control conditions shape quality. The practical capability is gene-delivery science. Keep the question, input provenance, method version, controls, uncertainty, review and next decision in one evidence receipt. That record keeps curiosity optimistic and claims proportional to what was actually measured. BTI and authorised collaborators control current processes, facilities and released results; product sponsors, quality systems and regulators control manufacturing and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Create a one-page evidence card for “RNA needs formulation and delivery” with the source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Successful cellular uptake is not clinical safety or efficacy.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Buffers, excipients, containers and temperature affect aggregation, degradation or particle properties. Stability studies use defined conditions and validated assays. Accelerated testing can inform risk but cannot perfectly predict every real storage history.

Scale-up changes oxygen, mixing, heat, stress and purification, so a successful small culture starts a new evidence stage rather than finishing development. The practical capability is formulation stability. Keep the question, input provenance, method version, controls, uncertainty, review and next decision in one evidence receipt. That record keeps curiosity optimistic and claims proportional to what was actually measured. BTI and authorised collaborators control current processes, facilities and released results; product sponsors, quality systems and regulators control manufacturing and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Create a one-page evidence card for “Formulation protects the product over time” with the source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A short stress study is not a complete shelf-life claim.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Teams identify critical quality attributes, material attributes and process parameters, then build evidence for acceptable ranges. This does not remove testing; it explains why controls should keep the process in a reliable region.

Analytical methods connect identity, purity, potency and process understanding, letting teams find variation before it reaches later decisions. The practical capability is quality-by-design reasoning. Keep the question, input provenance, method version, controls, uncertainty, review and next decision in one evidence receipt. That record keeps curiosity optimistic and claims proportional to what was actually measured. BTI and authorised collaborators control current processes, facilities and released results; product sponsors, quality systems and regulators control manufacturing and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Create a one-page evidence card for “Quality by design links parameters to outcomes” with the source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A design space is only as strong as its supporting evidence.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Biomanufacturing careers span cell biology, chemical engineering, analytics, automation, statistics, quality and regulatory science. Students can model growth curves or mass balances safely while documenting assumptions. Institutions control training and regulated responsibilities.

Cells, proteins and nucleic acids need different production and delivery strategies, with safety and regulation governing every translation step. The practical capability is biomanufacturing career preparation. Keep the question, input provenance, method version, controls, uncertainty, review and next decision in one evidence receipt. That record keeps curiosity optimistic and claims proportional to what was actually measured. BTI and authorised collaborators control current processes, facilities and released results; product sponsors, quality systems and regulators control manufacturing and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Create a one-page evidence card for “Students can combine biology and engineering” with the source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A classroom culture or calculation is not a validated production process.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Archive cell source and bank, media, vessel and controls, scale criterion, purification, assay versions, product attributes, formulation, stability, deviations, quality review and regulatory status. This lineage shows how the process supports the final claim.

Biomanufacturing treats the process as part of the product because cells, media, equipment and control conditions shape quality. The practical capability is evidence governance. Keep the question, input provenance, method version, controls, uncertainty, review and next decision in one evidence receipt. That record keeps curiosity optimistic and claims proportional to what was actually measured. BTI and authorised collaborators control current processes, facilities and released results; product sponsors, quality systems and regulators control manufacturing and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Create a one-page evidence card for “Keep a process-to-product evidence receipt” with the source, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: The latest authorised batch, quality and regulatory records control release.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter